Hydrazine DNA Damage Detection Method
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting DNA damage caused by ionizing radiation and oxidative stress lack sensitivity, specificity, speed, and reproducibility, particularly in clinical and field settings, and are not suitable for rapid triage or high-throughput assays, especially for detecting exposure to low to moderate levels of radiation.
Innovation Solution
The use of fluorescent or chromogenic hydrazine compounds that react with aldehyde moieties in DNA, such as 5-formyldeoxyuridine, to form stable hydrazones, allowing for direct detection and quantitation of DNA damage in biological samples without the need for extensive purification or washing steps, enabling real-time monitoring and adaptation to various analytical platforms.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If comprehensive analysis by mass spectrometry is used, then measurement precision is improved, but device complexity and loss of time increase
Solution Approach 1:
The patent extracts and detects specific aldehyde-containing DNA lesions (5-FodU, 8-oxodG) as biomarkers rather than analyzing all DNA components comprehensively. This selective extraction approach maintains measurement precision for radiation dosimetry while eliminating the need for complex mass spectrometry instrumentation, enabling simpler field-deployable assays
Solution Approach 2:
The patent changes the detection parameter from comprehensive molecular mass analysis to detection of specific chemical functional groups (aldehyde moieties) using colorimetric or fluorescent reagents. This parameter change simplifies the analytical instrumentation required while maintaining sufficient precision for radiation dose assessment
2Measurement precision
If DNA purification and complete hydrolysis are performed, then measurement precision is improved, but loss of time and productivity decrease
Solution Approach 1:
The patent performs preliminary detection of aldehyde lesions in intact or minimally processed DNA before any extensive purification or hydrolysis steps. By detecting the aldehyde functional groups directly in crude extracts using colorimetric/fluorescent reagents, the method achieves sufficient quantitative results without time-consuming DNA purification and complete hydrolysis procedures
Solution Approach 2:
The patent applies partial action by performing only the minimum necessary processing (crude extraction) rather than complete DNA purification and hydrolysis. This partial processing approach maintains adequate measurement precision for dosimetry while dramatically reducing assay time and increasing productivity for rapid triage applications
3Ease of operation
If antibody or avidin detection methods are used, then ease of operation is improved, but measurement precision and reliability worsen due to artifacts and lower sensitivity
Solution Approach 1:
The patent substitutes the mechanical/biological recognition system (antibody-antigen or avidin-biotin binding) with a direct chemical reaction system where aldehyde-specific reagents covalently bind to carbonyl groups on damaged bases. This substitution eliminates artifacts from non-specific binding while maintaining ease of operation and enhancing measurement precision through chemically specific detection
Solution Approach 2:
The patent introduces aldehyde-specific reagents (colorimetric or fluorescent) as intermediaries that directly react with carbonyl groups on oxidized bases. This intermediary approach replaces the indirect antibody/avidin detection system, eliminating artifacts from biological reagent variability while maintaining operational simplicity and improving detection accuracy through direct chemical specificity
4Ease of operation
If commercial ELISA or flow cytometry kits are used, then ease of operation is improved, but measurement precision deteriorates for rapid triage with stated statistical certainty
Solution Approach 1:
The patent changes the detection parameter from enzyme-linked immunosorbent assay readouts to direct colorimetric or fluorescent measurements of aldehyde-reagent adducts. This parameter change enables simpler, faster assays with sufficient precision for rapid triage by eliminating multi-step ELISA procedures and complex flow cytometry protocols while maintaining statistical certainty for dose assessment
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides a sensitive, robust, and rapid method for detecting DNA damage, capable of quantifying exposure to ionizing radiation with high accuracy and specificity, suitable for clinical and field use, and adaptable to multiple platforms, including flow cytometry and lateral flow bioassays, with minimal user training and no refrigeration requirements.
Implementation Method 1
The reactivity of the aldehyde moiety of 5-FodU makes it a particularly attractive target... combining the DNA sample with a fluorescent or pro-fluorescent, chromogenic or pro-chromogenic hydrazine compound to form a fluorescent DNA
Implementation Method 2
fluorescent or pro-fluorescent, chromogenic or pro-chromogenic hydrazine compounds that when bound to deoxyribonucleic acid ('DNA'), detect damage
Implementation Method 3
chromogenic or pro-chromogenic hydrazine compounds... detecting the fluorescent DNA or colored DNA by monitoring a fluorescent emission or saturation of color
Data Source
AI summary
The present invention is a method for detecting the extent of DNA damage in a subject suspected of having DNA damage wherein the damage results in the formation of aldehyde moieties in DNA comprising, obtaining a DNA sample from the subject, combining the DNA sample with a fluorescent, chromogenic, pro-fluorescent or pro-chromogenic hydrazine compound to from a fluorescent DNA, detecting the presence of the fluorescent DNA by monitoring the fluorescent emission and quantitating the fluorescent emission thereby determining the extent of DNA damage in the subject.